The latest quarterly R&D expense is $29.10 Million with a QoQ Growth of +23.83%. Research and Development (R&D) expenses represent the costs incurred by a company in developing new products, services, or processes.
Q2 FY2026 (2026-06-30).
Reported quarterly R&D expense; no daily interpolation. Q2 FY2026 (2026-06-30): $29.10M.
$29.10M
$29.10 Million
Q2 FY2026 · 2026-06-30
+23.83%
vs. $23.50M prior quarter
22
Quarters of data available
| Period | R&D Expense | QoQ Growth | YoY Growth |
|---|---|---|---|
| Q2 FY2026Period end 2026-06-30 | $29.10M | +23.83% | -13.77% |
| Q1 FY2026Period end 2026-03-31 | $23.50M | -19.24% | -32.09% |
| Q4 FY2025Period end 2025-12-31 | $29.10M | +12.36% | +409.45% |
| Q3 FY2025Period end 2025-09-30 | $25.90M | -23.25% | -45.80% |
| Q2 FY2025Period end 2025-06-30 | $33.75M | -2.48% | +486.90% |
| Q1 FY2025Period end 2025-03-31 | $34.61M | +505.84% | -7.21% |
| Q4 FY2024Period end 2024-12-31 | $5.71M | -88.05% | -91.43% |
| Q3 FY2024Period end 2024-09-30 | $47.79M | +731.08% | +12.83% |
| Q2 FY2024Period end 2024-06-30 | $5.75M | -84.58% | -82.89% |
| Q1 FY2024Period end 2024-03-31 | $37.30M | -44.07% | +7.69% |
| Q4 FY2023Period end 2023-12-31 | $66.68M | +57.44% | +19.06% |
| Q3 FY2023Period end 2023-09-30 | $42.35M | +26.06% | +67.06% |
| Q2 FY2023Period end 2023-06-30 | $33.60M | -2.99% | -27.17% |
| Q1 FY2023Period end 2023-03-31 | $34.63M | -38.16% | -29.84% |
| Q4 FY2022Period end 2022-12-31 | $56.00M | +120.91% | -1.66% |
| Q3 FY2022Period end 2022-09-30 | $25.35M | -45.04% | -54.82% |
| Q2 FY2022Period end 2022-06-30 | $46.13M | -6.54% | +22.63% |
| Q1 FY2022Period end 2022-03-31 | $49.36M | -13.33% | +33.16% |
| Q4 FY2021Period end 2021-12-31 | $56.95M | +1.48% | N/A |
| Q3 FY2021Period end 2021-09-30 | $56.11M | +49.18% | N/A |
| Q2 FY2021Period end 2021-06-30 | $37.62M | +1.48% | N/A |
| Q1 FY2021Period end 2021-03-31 | $37.07M | N/A | N/A |
Growth uses unique fiscal quarters. Missing or ambiguous prior periods render N/A.
